Comparative analysis of the trends in laryngeal cancer disease burden between China and the world from 1990 to 2021.
- 1Department of Otolaryngology Head and Neck Surgery, The First People's Hospital of Tianmen City (Tianmen Hospital Affiliated to Wuhan University of Science and Technology), Tianmen, Hubei, China.
Abstract
Laryngeal cancer remains an important public health concern, with substantial variation in disease burden across regions, age groups, and sexes. This study aimed to characterize temporal trends in the burden of laryngeal cancer in China from 1990 to 2021 and to compare age- and sex-specific patterns of incidence, prevalence, mortality, and disability-adjusted life years (DALYs) with global trends, using data from the Global Burden of Disease 1990 to 2021 study. Joinpoint regression was applied to calculate average annual percentage changes and corresponding 95% confidence intervals to quantify long-term trends. During the study period, China's age-standardized prevalence rate declined slightly from 1.82 to 1.789 per 100,000, while the global prevalence rate decreased more markedly from 3.072 to 2.293 per 100,000. In contrast, the age-standardized incidence rate in China increased from 7.83 to 9.864 per 100,000, whereas a global decline was observed from 15.274 to 12.558 per 100,000. Age-standardized mortality and DALY rates in China decreased substantially, from 40.372 to 22.726 per 100,000 and from 1.59 to 0.937 per 100,000, respectively, paralleling but remaining lower than global reductions. The average annual percentage changes in China for DALYs, mortality, incidence, and prevalence were -1.89, -1.73, -0.10, and 0.74, respectively, compared with global values of -1.60, -1.47, -0.95, and -0.65. Notably, males consistently exhibited a significantly higher burden than females across all indicators. These findings highlight divergent trends between China and the global population, particularly the rising incidence in China despite declining mortality and DALYs, underscoring the need to strengthen early screening and prevention strategies for laryngeal cancer, especially among high-risk male populations.
Related
- Burden, Risk Factors, and Temporal Trends of Ovarian Cancer in Postmenopausal Women Aged 55 Years and Older: A Comparative Analysis in India, China, and the United States Based on the Global Burden of Disease Study 2023.
- Trends, Risk Factors, and Future Burden of Female Breast Cancer in China and Other G20 Countries, 1990-2050: A Comparative Global Burden of Disease 2023 Analysis.
- Global trends in young and older adult esophageal cancer burden from 1990 to 2021 : An observational analysis for the Global Burden of Disease study 2021
- Trends and Patterns in Gastrointestinal Cancer Burden in Asia, 1990–2023: Evidence from the Global Burden of Disease Study 2023
- Burden, trends and predictions of esophageal cancer in the top five GDP countries: a systematic analysis based on the Global Burden of Disease 2023 study.
BibTeX
@article{liao2026comparative,
title = {{Comparative analysis of the trends in laryngeal cancer disease burden between China and the world from 1990 to 2021.}},
author = {Hongming Liao and Hongyong Wang},
journal = {Medicine},
year = {2026},
month = oct,
doi = {10.1097/md.0000000000051127},
url = {https://europepmc.org/article/MED/42888608},
note = {CC BY},
}
RIS
TY - JOUR
TI - Comparative analysis of the trends in laryngeal cancer disease burden between China and the world from 1990 to 2021.
AU - Hongming Liao
AU - Hongyong Wang
PY - 2026
DA - 2026/10/01
JO - Medicine
DO - 10.1097/md.0000000000051127
UR - https://europepmc.org/article/MED/42888608
AB - Laryngeal cancer remains an important public health concern, with substantial variation in disease burden across regions, age groups, and sexes. This study aimed to characterize temporal trends in the burden of laryngeal cancer in China from 1990 to 2021 and to compare age- and sex-specific patterns of incidence, prevalence, mortality, and disability-adjusted life years (DALYs) with global trends, using data from the Global Burden of Disease 1990 to 2021 study. Joinpoint regression was applied to calculate average annual percentage changes and corresponding 95% confidence intervals to quantify long-term trends. During the study period, China's age-standardized prevalence rate declined slightly from 1.82 to 1.789 per 100,000, while the global prevalence rate decreased more markedly from 3.072 to 2.293 per 100,000. In contrast, the age-standardized incidence rate in China increased from 7.83 to 9.864 per 100,000, whereas a global decline was observed from 15.274 to 12.558 per 100,000. Age-standardized mortality and DALY rates in China decreased substantially, from 40.372 to 22.726 per 100,000 and from 1.59 to 0.937 per 100,000, respectively, paralleling but remaining lower than global reductions. The average annual percentage changes in China for DALYs, mortality, incidence, and prevalence were -1.89, -1.73, -0.10, and 0.74, respectively, compared with global values of -1.60, -1.47, -0.95, and -0.65. Notably, males consistently exhibited a significantly higher burden than females across all indicators. These findings highlight divergent trends between China and the global population, particularly the rising incidence in China despite declining mortality and DALYs, underscoring the need to strengthen early screening and prevention strategies for laryngeal cancer, especially among high-risk male populations.
SN - 0304-5412
SN - 1536-5964
ER -